Literature DB >> 21205691

Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota.

D C Hesdorffer1, G Logroscino, E K T Benn, N Katri, G Cascino, W A Hauser.   

Abstract

OBJECTIVES: Previous studies that have assessed the risk of developing epilepsy have failed to account for the competing risk of death, significant in the elderly where epilepsy incidence is highest. We report the lifetime risk for epilepsy, accounting for the competing risk of mortality.
METHODS: Lifetime risk and cumulative incidence of epilepsy were examined among Rochester, MN, residents between 1960 and 1979. Age-, gender-, and calendar year-specific deaths were obtained for Rochester, MN. Lifetime risk was calculated as the conditional probability of developing epilepsy by a specific age for a person reaching that age who had not yet developed epilepsy. Lifetime risk and cumulative incidence were compared for age and time period.
RESULTS: We identified 412 individuals with incident epilepsy diagnosed between January 1, 1960, and December 31, 1979. Lifetime risk was 1.6% to age 50 and 3.0% to age 80; cumulative incidence was 1.7% to age 50 and 3.4% to age 80. Similar differences were seen across epilepsy etiologies. Lifetime risk through 87 years of age increased over time from 3.5% in 1960-1969 to 4.2% in 1970-1979.
CONCLUSIONS: One in 26 people will develop epilepsy during their lifetime. Lifetime risk provides an estimate of an individual's risk for epilepsy over his or her remaining lifetime, translates into the number of people who are expected to develop epilepsy, and assists health care planners as they estimate service needs for epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 21205691      PMCID: PMC3032191          DOI: 10.1212/WNL.0b013e318204a36a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Lifetime risk of developing coronary heart disease.

Authors:  D M Lloyd-Jones; M G Larson; A Beiser; D Levy
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

2.  Incidence and remaining lifetime risk of Parkinson disease in advanced age.

Authors:  Jane A Driver; Giancarlo Logroscino; J Michael Gaziano; Tobias Kurth
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

3.  Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1993 Jul-Aug       Impact factor: 5.864

Review 4.  Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study.

Authors:  Sudha Seshadri; Philip A Wolf
Journal:  Lancet Neurol       Date:  2007-12       Impact factor: 44.182

5.  Cancer incidence: life table risk versus cumulative risk.

Authors:  L J Schouten; H Straatman; L A Kiemeney; A L Verbeek
Journal:  J Epidemiol Community Health       Date:  1994-12       Impact factor: 3.710

6.  Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

Authors:  W A Hauser; J F Annegers; L T Kurland
Journal:  Epilepsia       Date:  1993 May-Jun       Impact factor: 5.864

  6 in total
  75 in total

1.  Familial cosegregation of rare genetic variants with disease in complex disorders.

Authors:  Ingo Helbig; Susan E Hodge; Ruth Ottman
Journal:  Eur J Hum Genet       Date:  2012-09-26       Impact factor: 4.246

2.  What's at stake? Genetic information from the perspective of people with epilepsy and their family members.

Authors:  Sara Shostak; Dana Zarhin; Ruth Ottman
Journal:  Soc Sci Med       Date:  2011-07-23       Impact factor: 4.634

Review 3.  Resolving the Micro-Macro Disconnect to Address Core Features of Seizure Networks.

Authors:  Jordan S Farrell; Quynh-Anh Nguyen; Ivan Soltesz
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

4.  cEEG electrode-related pressure ulcers in acutely hospitalized patients.

Authors:  Lidia M V R Moura; Thiago S Carneiro; David Kwasnik; Valdery F Moura; Christine S Blodgett; Joseph Cohen; Mary McKenna Guanci; Daniel B Hoch; John Hsu; Andrew J Cole; M Brandon Westover
Journal:  Neurol Clin Pract       Date:  2017-02

5.  Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study.

Authors:  Elaine C Wirrell; Brandon R Grossardt; Lily C L Wong-Kisiel; Katherine C Nickels
Journal:  Epilepsy Res       Date:  2011-04-08       Impact factor: 3.045

6.  Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.

Authors:  Jacqueline A Hubbard; Jenny I Szu; Jennifer M Yonan; Devin K Binder
Journal:  Exp Neurol       Date:  2016-05-04       Impact factor: 5.330

Review 7.  Sex differences in the anticonvulsant activity of neurosteroids.

Authors:  Doodipala Samba Reddy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

8.  Using EHRs to advance epilepsy care.

Authors:  Juma S Mbwana; Zachary M Grinspan; Russell Bailey; Madison Berl; Jeffrey Buchhalter; Adrian Bumbut; Zach Danner; Tracy Glauser; Angie Glotstein; Howard Goodkin; Brian Jacobs; Lisa Jones; Barbara Kroner; Gardiner Lapham; Tobias Loddenkemper; Demetrius M Maraganore; Doug Nordli; William D Gaillard
Journal:  Neurol Clin Pract       Date:  2019-02

Review 9.  Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report.

Authors:  Mary Jane England; Catharyn T Liverman; Andrea M Schultz; Larisa M Strawbridge
Journal:  Epilepsy Behav       Date:  2012-10-05       Impact factor: 2.937

10.  Use of anterior temporal lobectomy for epilepsy in a community-based population.

Authors:  Jamie J Van Gompel; Ruth Ottman; Gregory A Worrell; Richard Marsh; Nicholas M Wetjen; Gregory D Cascino; Fredric B Meyer
Journal:  Arch Neurol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.